000 | 01613 a2200313 4500 | ||
---|---|---|---|
008 | 051207s xx 000 0 eng | ||
022 | _a1522-3248; | ||
050 | _aAC1.S5 | ||
082 | _a050 | ||
100 | _aOjcius, David M., | ||
245 | 0 |
_aCan Chlamydia Be Stopped?. _cDavid M. Ojcius and others. |
|
260 |
_bScientific American, _c2005. |
||
440 |
_aSIRS Enduring Issues 2006. _nArticle 75, _pHuman Relations, _x1522-3248; |
||
500 | _aArticles Contained in SIRS Enduring Issues 2006. | ||
500 | _aOriginally Published: Can Chlamydia Be Stopped?, May 2005; pp. 72-79. | ||
520 | _a"Ask the average American about chlamydia, and you will probably evoke an uneasy cringe. Most people think immediately of one of the world's most common sexually transmitted diseases (STDs). But the term actually refers to an entire genus of tiny bacteria that can ignite a variety of serious illnesses." (SCIENTIFIC AMERICAN) This article reveals how "recent discoveries are suggesting new ways to curtail the spread" of chlamydia, "a rampant sexually transmitted disease, the world's leading cause of preventable blindness and a possible contributor to heart disease." | ||
599 | _aRecords created from non-MARC resource. | ||
650 | _aApoptosis | ||
650 | _aAtherosclerosis | ||
650 | _aChlamydia | ||
650 | _aChlamydia infections | ||
650 | _aCytokines | ||
650 |
_aEye _xDiseases |
||
650 | _aImmune response | ||
650 | _aT cells | ||
650 |
_aVaccines _xResearch |
||
710 |
_aProQuest Information and Learning Company _tSIRS Enduring Issues 2006, _pHuman Relations. _x1522-3248; |
||
942 | _c UKN | ||
999 |
_c37590 _d37590 |